Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants
Read more…
The Study:
ImpactsofregularuseofivermectinonCOVID019outcomes.TheIvermectinItajaStudy2.July2022.